CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
47.91
-2.52 (-5.00%)
At close: Feb 21, 2025, 4:00 PM
47.67
-0.24 (-0.50%)
After-hours: Feb 21, 2025, 7:45 PM EST
CRISPR Therapeutics AG Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -366.25 | -153.61 | -650.18 | 377.66 | -348.87 | |
| Depreciation & Amortization | 19.26 | 19.84 | 24.17 | 17.95 | 9.18 | |
| Asset Writedown & Restructuring Costs | - | 2.5 | - | - | - | |
| Stock-Based Compensation | 86.57 | 81.03 | 97.95 | 102.39 | 66.02 | |
| Other Operating Activities | -38.62 | -16.55 | 12.47 | 14.11 | 1.86 | |
| Change in Accounts Receivable | 175 | -200 | 0.31 | -0.16 | -0.05 | |
| Change in Accounts Payable | -27.28 | -20.25 | 5.16 | 37.51 | 25.75 | |
| Change in Unearned Revenue | -1.95 | 5.79 | -1.01 | -0.78 | 1.38 | |
| Change in Other Net Operating Assets | 10.5 | 20.87 | 15.39 | -9.71 | 6.36 | |
| Operating Cash Flow | -142.77 | -260.38 | -495.74 | 538.97 | -238.37 | |
| Capital Expenditures | -1.9 | -9.47 | -37.19 | -81.71 | -18.36 | |
| Sale (Purchase) of Intangibles | - | -2.5 | - | - | - | |
| Investment in Securities | -278.58 | 386.62 | -221.47 | -953.73 | -522.81 | |
| Investing Cash Flow | -280.48 | 374.65 | -258.66 | -1,035 | -541.17 | |
| Issuance of Common Stock | 331.98 | 62.66 | 38.59 | 250.95 | 1,016 | |
| Financing Cash Flow | 331.98 | 62.66 | 38.59 | 250.95 | 1,016 | |
| Foreign Exchange Rate Adjustments | -0.02 | 0.07 | -0.08 | -0.01 | 0.04 | |
| Miscellaneous Cash Flow Adjustments | - | -0 | - | - | - | |
| Net Cash Flow | -91.29 | 177.01 | -715.88 | -245.52 | 236.66 | |
| Free Cash Flow | -144.68 | -269.85 | -532.93 | 457.27 | -256.72 | |
| Free Cash Flow Margin | -387.72% | -72.69% | -44484.89% | 49.98% | -35705.70% | |
| Free Cash Flow Per Share | -1.71 | -3.41 | -6.85 | 5.69 | -3.89 | |
| Levered Free Cash Flow | -29.27 | -238.97 | -337.58 | 284.82 | -112.91 | |
| Unlevered Free Cash Flow | -29.27 | -238.97 | -337.58 | 284.82 | -112.91 | |
| Change in Net Working Capital | -158.41 | 188.78 | 1.78 | -12.73 | -51.77 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.